Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Expert Opinion on Therapeutic Patents
|
January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)
Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Expert Opinion on Therapeutic Patents
|
November 16, 2012
Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators
Christina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz, et al.
Future Medicinal Chemistry
|
January 30, 2016
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound
Christina Lamers, Daniel Merk, Matthias Gabler, et al.
Bioorganic & Medicinal Chemistry
|
January 14, 2015
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligands
Daniel Merk, Christina Lamers, Julia Weber, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties
Daniel Flesch, Matthias Gabler, Andreas Lill, et al.
Bioorganic & Medicinal Chemistry
|
April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2015
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease
Daniel Flesch, Julia Ness, Christina Lamers, et al.
European Journal of Pharmacology
|
March 10, 2015
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists
Tilo Knape, Daniel Flesch, Laura Kuchler, et al.
Journal of Medicinal Chemistry
|
July 28, 2017
Nonacidic Farnesoid X Receptor Modulators
Daniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Expert Opinion on Therapeutic Patents
|
January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)
Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Expert Opinion on Therapeutic Patents
|
November 16, 2012
Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators
Christina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz, et al.
Future Medicinal Chemistry
|
January 30, 2016
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound
Christina Lamers, Daniel Merk, Matthias Gabler, et al.
Bioorganic & Medicinal Chemistry
|
January 14, 2015
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligands
Daniel Merk, Christina Lamers, Julia Weber, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties
Daniel Flesch, Matthias Gabler, Andreas Lill, et al.
Bioorganic & Medicinal Chemistry
|
April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2015
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease
Daniel Flesch, Julia Ness, Christina Lamers, et al.
European Journal of Pharmacology
|
March 10, 2015
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists
Tilo Knape, Daniel Flesch, Laura Kuchler, et al.
Journal of Medicinal Chemistry
|
July 28, 2017
Nonacidic Farnesoid X Receptor Modulators
Daniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Page
of 1